Investors
Overview
Havn Life is focused on the rapidly growing field of psychedelic medicine. We have the opportunity to lead the standardization of psychedelic supply to shift human performance & mental health paradigms.
- DEFINED ROUTE TO NATURAL HEALTH PRODUCTS MARKET.
- PRODUCT FORMULATION OF EFFECTIVE MICRODOSING OF NOVEL PSYCHOACTIVE COMPOUNDS.
- MANAGEMENT TEAM WITH EXTENSIVE CLINICAL & NHP PRODUCT DEVELOPMENT EXPERIENCE.
- DEVELOPING STATE-OF-THE-ART MYCOLOGY LAB FOR PSYCHEDELIC EXTRACTION.
- PARTNERSHIP WITH CANADIAN VETERANS FOR PHASE 1 PRE-CLINICAL RESEARCH.
- RECEIVED FIRST HEALTH CANADA LICENSE IN 2020.
Our Team
Collaboration across disciplines
Creating positive patient experiences and mental health outcomes
Vic Neufeld
Executive Chairman
CEO of Aphria for 5 years during large scale build up to one of the leading cannabis producers in the world.
Tim Moore
Chief Executive Officer
Former CEO of Green Growth Brands, from IPO through to Jan 2019, leading the Company to ~$1 Billion market cap.
Susan Chapelle
Executive Vice-President, Research & Development
Recognized thought leader in the Canadian Cannabis space. 25 years of leadership experience in healthcare, non-profit, and private sectors in Canada.
Gary Leong
Chief Scientific Officer
Former Chief Scientific Officer at Aphria Inc. where he established and oversaw the Quality Assurance, Quality Control, Regulatory Affairs & Research and Development functions.
Dr. Ivan Casselman
Chief Psychedelic Officer
Extensive nutraceutical formulation experience, with several products available in legal cannabis markets in North America.
Alexzander Samuelsson
Chief Research Officer
Lead chemist of a publicly traded extraction company, Alexzander developed intellectual property and patented methods in the extraction of cannabis oils.
Eli Dusenbury
Chief Financial Officer
Served as a consultant for audit and public practice firms in both Canada and the US and has held CFO positions for publicly traded companies.
Juliana Mollica
Director of Innovation and Quality Assurance
Led projects as the quality assurance and compliance manager for cannabis and pharmaceutical companies to ensure maintenance of GMP requirements, developing QMS for multi-site projects, compliance training programs, and increasing compliance and quality rates.
Rick Brar
Vice Chairman
CEO & Chairman of Brains Bioceutical Corp. A global manufacturer and distributor of Cannabinoid API.
Barinder Rasode
President
Served two terms as elected Councilor for the City of Surrey. Served on the Board of BC’s largest health authority, Fraser Health, where she was responsible for a budget over $3 Billion.
Tim Laidler
Director
Executive Director of the Institute for Veterans Education and Transition at UBC. The institute focuses on supporting the needs of veterans in the community as well as supporting cutting edge research with Veterans.
Sheila Copps
Advisor
The Honourable Sheila Copps was the first woman to ever hold the position of Deputy Prime Minister and served for ten years in the federal cabinet.
Allan Oberman
Advisor
Served as CEO for Concordia International, an international speciality pharmaceutical company with sales in 90 countries and over 200 medicines.
Dr. David Mokler
Advisor
Expert specialist in neuropharmacology, psychopharmacology, substance abuse, drug abuse, brain development, dopamine and serotonin including work relevant to the 5HT2a receptors in psychedelics
Consultants
Legal Counsel
Cassels
cassels.com
Auditor
De Visser Gray LLP
devissergray.com
Transfer Agent
Odyssey Trust Company
odysseytrust.com
LATEST NEWS
Havn Life Sciences announces $5.46 million warrant exercise
Havn Life announces Voluntary Escrow of 6,300,000 Shares
CORPORATE PRESENTATION